Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Melanoma as a topic and a Related Topics link to MedlinePlus Genetics on the study page.SummaryDifference0.1%

- Check23 days agoChange DetectedExpanded the Locations section to include a comprehensive list of participating sites across multiple states and added a Revision: v3.3.3 tag. Removed the prior state-specific location blocks and the HHS Vulnerability Disclosure section.SummaryDifference2%

- Check31 days agoChange DetectedDeleted the study topic 'Melanoma' and the related topic 'MedlinePlus Genetics' from the page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page footer revision tag updated from v3.2.0 to v3.3.2. No study data or core functionality appears to be affected.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the page, and removed the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.